WPRIM Management System> DCMS> Chinese Journal of Endocrinology and Metabolism> 2009> 25> 1

Volume: 25 Issue: 1

1. Comparison of serum lipid profiles and the risk factors between the Guangxi Bai Ku Yao and Han nationalities Page:66—67
2. Clinical and epigenetic study of a case with adrenal hypoplasia congenita caused by a novel DAX-1 gene mutation Page:62—63
3. Study on a novel androgen receptor gene mutation causing androgen insensitivity syndrome Page:58—61
4. Association of plasma creatinine with lactic acid level in type 2 diabetic patients with normal renal function Page:42—45
5. Outcome and influencing factors of integrated intensive intervention in participants with impaired glucose regulation for two years Page:30—33
6. Elevated circulating free fatty acids level causes pancreatic islet β-cell dysfunction via oxidative stress Page:13—16
7. Evaluation of various questionnaires for screening diabetes mellitus in Chinese population Page:64—65
8. Comparison of the excursion of blood glucose in type 2 diabetes injected glargine and human isophane insulin Page:39—41
9. Screening and functional analysis of variation in NeuroD1 gene in early-onset type 2 diabetic pedigrees Page:34—38
10. Effects of advanced glycosylation end products on interactions between cis-elements and trans-acting factors of hepatic insulin receptor gene Page:17—21
11. Strategy on intensive glycemic control and cordiovascular disease prevention in type 2 diabetes mellitns Page:1—4
12. Insulin resistance syndromes of monogenic mutations Page:120—123
13. Influence of smoking on the gene expression of insulin receptor substrate 2 in rat muscle tissue Page:94—95
14. Effect of glucocorticoid on the expression of PGC-1α mRNA in brown adipose tissue and skeletal muscle of obese rats fed with high-fat diet Page:92—94
15. Study on hNIS mediated transferring gene99mTcO-4 imaging and mI treatment in xenografted ovariancancer Page:83—86
16. Ultrasound ablation and balloon angioplasty in treating peripheral arterial occlusion in diabetes mellitus Page:56—57
17. Association of body composition and β-cell function in obese females with normal glucose metabolism Page:52—55
18. Combination of glucotoxicity and lipitoxicity impairs pancreatic β-cell function Page:28—29
19. Role of pancreatic stellate cell activation in islet fibrosis of rats fed with high-fat Page:25—27
20. Relationship between Xsp Ⅰ polymorphism in the exon 4 of LDL receptor gene and hypercholesterolemia Page:49—51
21. Relationship between the genetic variants in SLCOI B1 gene and the response to repaglinide treatment in newly-diagnosed type 2 diabetic patients Page:46—48
22. Impact of glucotoxicity on TC1-6 cell glucagon secretion Page:9—12
23. Study on pancreatic islet β-cell function and insulin sensitivity at different stages of lifetime in rats born with intrauterine growth retardation Page:87—89
24. Protective effects of lisinopril on peripheral neuropathy in diabetic rats Page:79—82
25. Angiotensin type 1 receptor blockers telmisartan and irbesartan activate PPARα Page:70—74
26. Effects of "glucotoxicity", "lipotoxicity" and "glucolipotoxicity" on islet β-cells Page:5—8
27. Osteoimmunology of postmenopausal osteoporosis Page:124—126
28. Molecular mechanism of SH2-Bβ in regulating JAK2/STAT3 during development of obesity Page:90—91
29. Proinsulin gene therapy in diabetic rats——Comparison of the effects on blood glucose by intraportal infusion and intramuscular injection Page:75—78
30. Association of serum matrix metalloproteinase-9 levels and C-reactive protein with peripheral vascular disease of lower limbs in type 2 diabetes mellitus Page:68—69
31. "Metabolic memory" of hyperglycemia Page:增录7a—10
32. Impact of postprandial hyperglycemia control on the treat-to-target blood glucose management Page:增录4a—7
33. Retrospective on postprandial glycemia study during past 10 years in China and its prospectives Page:增录1a—2
34. Liraglutide: A novel therapy for type 2 diabetes——Report of "Diabetes Dialogue" International Forum Page:附录1b—3
35. "Chinese guideline for type 2 diabetes mellitus" comprises Chinese characters Page:增录3a—4

©2019 - Present World Health Organization Regional Office for the Western Pacific. All Rights Reserved.